ClinVar Genomic variation as it relates to human health
NM_000203.5(IDUA):c.235G>A (p.Ala79Thr)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000203.5(IDUA):c.235G>A (p.Ala79Thr)
Variation ID: 195038 Accession: VCV000195038.24
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 4p16.3 4: 987885 (GRCh38) [ NCBI UCSC ] 4: 981673 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 8, 2017 Sep 29, 2024 Nov 1, 2021 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000203.5:c.235G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000194.2:p.Ala79Thr missense NM_022042.4:c.*948C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
3 prime UTR NM_134425.4:c.576+3243C>T intron variant NM_213613.4:c.*948C>T 3 prime UTR NR_110313.1:n.323G>A non-coding transcript variant NC_000004.12:g.987885G>A NC_000004.11:g.981673G>A NG_008103.1:g.5889G>A NG_033042.1:g.10552C>T LRG_1277:g.5889G>A LRG_1277t1:c.235G>A LRG_1277p1:p.Ala79Thr - Protein change
- A79T
- Other names
- -
- Canonical SPDI
- NC_000004.12:987884:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.01018 (A)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00239
Exome Aggregation Consortium (ExAC) 0.00362
The Genome Aggregation Database (gnomAD) 0.00910
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00964
Trans-Omics for Precision Medicine (TOPMed) 0.00964
1000 Genomes Project 0.01018
1000 Genomes Project 30x 0.01218
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
IDUA | - | - |
GRCh38 GRCh37 |
1390 | 2153 | |
SLC26A1 | - | - |
GRCh38 GRCh37 |
3 | 765 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Benign/Likely benign; other (6) |
criteria provided, multiple submitters, no conflicts
|
Sep 18, 2018 | RCV000422439.17 | |
Benign; other (3) |
criteria provided, multiple submitters, no conflicts
|
Dec 26, 2018 | RCV000708549.11 | |
Likely benign (1) |
criteria provided, single submitter
|
May 16, 2018 | RCV000674553.2 | |
Benign (2) |
criteria provided, single submitter
|
Nov 1, 2021 | RCV001194419.5 | |
Likely benign (1) |
criteria provided, single submitter
|
Jul 19, 2021 | RCV002500480.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Benign
(Jan 27, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: not provided
Allele origin:
germline
|
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Accession: SCV000511059.1
First in ClinVar: Mar 08, 2017 Last updated: Mar 08, 2017 |
|
|
other
(May 25, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000227056.5
First in ClinVar: Jun 29, 2015 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 16
Sex: mixed
|
|
Likely benign
(May 16, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Hurler syndrome
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000799908.1
First in ClinVar: Aug 05, 2018 Last updated: Aug 05, 2018 |
|
|
other
pseudodeficiency allele
(Dec 26, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Mucopolysaccharidosis type I
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000837659.2
First in ClinVar: Oct 10, 2018 Last updated: Aug 14, 2019 |
|
|
Benign
(Apr 28, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Mucopolysaccharidosis type 1
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001317785.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. (less)
|
|
Benign
(Sep 18, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001784074.1
First in ClinVar: Aug 14, 2021 Last updated: Aug 14, 2021 |
Comment:
This variant is associated with the following publications: (PMID: 27939258)
|
|
Benign
(Nov 01, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV001363959.2
First in ClinVar: Jun 22, 2020 Last updated: Dec 25, 2021 |
Comment:
Variant summary: IDUA c.235G>A (p.Ala79Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging … (more)
Variant summary: IDUA c.235G>A (p.Ala79Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0031 in 270526 control chromosomes, predominantly at a frequency of 0.031 within the African or African-American subpopulation in the gnomAD database, including 9 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 12 fold of the estimated maximal expected allele frequency for a pathogenic variant in IDUA causing Mucopolysaccharidosis Type 1 phenotype (0.0027), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. The variant, c.235G>A, also has been reported in the literature as a well-known pseudodeficiency allele, prevalent in the African American subpopulation. Individuals with pseudodeficiency allele(s) exhibit decreased alpha-L-iduronidase enzyme activity in biochemical assays using artificial substrates, but otherwise show no evidence of disease (see e.g. in Clarke_2016). Seven ClinVar submitters (evaluation after 2014) cite the variant as benign/likely benign pseudodeficiency allele (n=6) or VUS (n=1). Based on the evidence outlined above, the variant was classified as benign. (less)
|
|
Likely benign
(Jul 19, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Nephrolithiasis susceptibility caused by SLC26A1
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002811181.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Likely benign
(-)
|
criteria provided, single submitter
Method: not provided
|
not provided
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Breakthrough Genomics, Breakthrough Genomics
Accession: SCV005263615.1
First in ClinVar: Sep 29, 2024 Last updated: Sep 29, 2024 |
|
|
Uncertain significance
(Jul 27, 2016)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
unknown
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV000801292.1
First in ClinVar: Aug 04, 2018 Last updated: Aug 04, 2018 |
|
|
Likely benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Study: VKGL Data-share Consensus
Accession: SCV001800421.1 First in ClinVar: Aug 21, 2021 Last updated: Aug 21, 2021 |
|
|
Benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not specified
Affected status: yes
Allele origin:
germline
|
Clinical Genetics, Academic Medical Center
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001921769.1 First in ClinVar: Sep 24, 2021 Last updated: Sep 24, 2021 |
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Mucopolysaccharidosis type 1
Affected status: unknown
Allele origin:
germline
|
GeneReviews
Accession: SCV002016347.2
First in ClinVar: Nov 20, 2021 Last updated: Oct 01, 2022 |
Comment:
Pseudodeficiency variants
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Mucopolysaccharidosis Type I. | Adam MP | - | 2024 | PMID: 20301341 |
The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I. | Polo G | Clinical chemistry and laboratory medicine | 2020 | PMID: 32432561 |
Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management. | Clarke LA | The Journal of pediatrics | 2017 | PMID: 27939258 |
Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry. | Elliott S | Molecular genetics and metabolism | 2016 | PMID: 27238910 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=IDUA | - | - | - | - |
Text-mined citations for rs58037052 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.